4.45
Finanzdaten der Dna X Inc-Aktie (SONM)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
44.90%
16.21
|
11.19 | 16.72 | 14.98 | 15.02 |
| Cost Of Revenue |
39.18%
14.40
|
10.35 | 8.365 | 15.17 | 10.79 |
| Gross Profit |
114.91%
1.816
|
0.845 | 8.356 | -0.183 | 4.232 |
|
|
23.51%
5.796
|
7.577 | 7.711 | 21.92 | 6.608 |
| Interest Income/Expense |
110.56%
0.339
|
0.161 | 0.071 | - | - |
| Benefits Costs and Expenses |
12.69%
20.88
|
18.53 | 16.13 | 36.65 | 17.42 |
| Costs And Expenses |
12.69%
20.88
|
18.53 | 16.13 | 36.65 | 17.42 |
| Depreciation and Amortization |
19.45%
0.952
|
0.797 | 1.055 | 0.914 | 0.918 |
| Operating Income/Loss |
40.88%
-3.98
|
-6.732 | 0.645 | -22.10 | -2.376 |
| Income/Loss From Continuing Operations Before Tax |
36.44%
-4.663
|
-7.336 | 0.59 | -21.67 | -2.395 |
| Income Tax Expense/Benefit |
35.25%
0.09
|
0.139 | 0.132 | -0.053 | 0.117 |
| Income/Loss From Continuing Operations After Tax |
36.41%
-4.753
|
-7.475 | 0.458 | -21.61 | -2.512 |
|
|
36.41%
-4.753
|
-7.475 | 0.458 | -21.61 | -2.512 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
89.64%
0.9849
|
9.5106 | 5.8398 | 0.0599 | 4.849 |
| Diluted Average Shares |
89.64%
0.9849
|
9.5106 | 5.8684 | 0.0599 | 4.849 |
| Basic Earnings Per Share |
511.39%
-4.83
|
-0.79 | 0.08 | -4.55 | -0.52 |
| Diluted Earnings Per Share |
511.39%
-4.83
|
-0.79 | 0.08 | -4.55 | -0.52 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):